MicroRNA 329 Suppresses Angiogenesis by Targeting CD146

Molecular and Cellular Biology

Volumn 33, Issue 18, 2013, Pages 3689-3699

  Wang, Ping ^a,b   Luo, Yongting ^a   Duan, Hongxia ^a,b   Xing, Shu ^a,b   Zhang, Jianlin ^a,b   Lu, Di ^a   Feng, Jing ^a   Yang, Dongling ^a   Song, Lina ^a   Yan, Xiyun ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD146 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 329; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

3' UNTRANSLATED REGION; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTIGENS, CD146; BASE SEQUENCE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICE, SCID; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RETINAL NEOVASCULARIZATION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883542972     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00343-13     Document Type: Article

References (50)

1. Carmeliet P, Jain RK. 2011. Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298-307.
2. Chung AS, Ferrara N. 2011. Developmental and pathological angiogenesis. Annu. Rev. Cell Dev. Biol. 27:563-584.
3. Potente M, Gerhardt H, Carmeliet P. 2011. Basic and therapeutic aspects of angiogenesis. Cell 146:873-887.
4. Sapieha P, Joyal JS, Rivera JC, Kermorvant-Duchemin E, Sennlaub F, Hardy P, Lachapelle P, Chemtob S. 2010. Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J. Clin. Invest. 120:3022-3032.
5. Griffioen AW, Molema G. 2000. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52:237-268.
6. Grothey A, Galanis E. 2009. Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nat. Rev. Clin. Oncol. 6:507-518.
7. Folkman J. 1971. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1182-1186.
8. Wang Z, Yan X. 2013. CD146, a multi-functional molecule beyond adhesion. Cancer Lett. 330:150-162.
9. So JH, Hong SK, Kim HT, Jung SH, Lee MS, Choi JH, Bae YK, Kudoh T, Kim JH, Kim CH. 2010. Gicerin/Cd146 is involved in zebrafish cardiovascular development and tumor angiogenesis. Genes Cells 15:1099-1110.
10. Daniel L, Bardin N, Moal V, Dignat-George F, Berland Y, Figarella-Branger D. 2005. Tubular CD146 expression in nephropathies is related to chronic renal failure. Nephron Exp. Nephrol. 99:e105-e111.
11. Tsiolakidou G, Koutroubakis IE, Tzardi M, Kouroumalis EA. 2008. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Dig. Liver Dis. 40:673-679.
12. Neidhart M, Wehrli R, Bruhlmann P, Michel BA, Gay RE, Gay S. 1999. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis. Arthritis Rheum. 42:622-630.
13. Kang Y, Wang F, Feng J, Yang D, Yang X, Yan X. 2006. Knockdown of CD146 reduces the migration and proliferation of human endothelial cells. Cell Res. 16:313-318.
14. Zheng C, Qiu Y, Zeng Q, Zhang Y, Lu D, Yang D, Feng J, Yan X. 2009. Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization. Int. J. Biochem. Cell Biol. 41:2163-2172.
15. Jiang T, Zhuang J, Duan H, Luo Y, Zeng Q, Fan K, Yan H, Lu D, Ye Z, Hao J, Feng J, Yang D, Yan X. 2012. CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis. Blood 120:2330-2339.
16. Zhuang J, Jiang T, Lu D, Luo Y, Zheng C, Feng J, Yang D, Chen C, Yan X. 2010. NADPH oxidase 4 mediates reactive oxygen species induction of CD146 dimerization in VEGF signal transduction. Free Radic. Biol. Med. 49:227-236.
17. Yan X, Lin Y, Yang D, Shen Y, Yuan M, Zhang Z, Li P, Xia H, Li L, Luo D, Liu Q, Mann K, Bader BL. 2003. A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood 102:184-191.
18. Carthew RW, Sontheimer EJ. 2009. Origins and mechanisms of miRNAs and siRNAs. Cell 136:642-655.
19. Fish JE, Srivastava D. 2009. MicroRNAs: opening a new vein in angiogenesis research. Sci. Signal. 2:pe1. doi:10.1126/scisignal.252pe1.
20. Urbich C, Kuehbacher A, Dimmeler S. 2008. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res. 79: 581-588.
21. Wang S, Olson EN. 2009. AngiomiRs-key regulators of angiogenesis. Curr. Opin. Genet. Dev. 19:205-211.
22. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN. 2008. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15:261-271.
23. Wurdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J, Weissleder R, Breakefield XO, Krichevsky AM. 2008. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 14:382-393.
24. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, Mac-Menamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. 2005. Combinatorial microRNA target predictions. Nat. Genet. 37:495-500.
25. Sethupathy P, Megraw M, Hatzigeorgiou AG. 2006. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat. Methods 3:881-886.
26. Rajewsky N. 2006. microRNA target predictions in animals. Nat. Genet. 38(Suppl):S8-S13.
27. Luo Y, Zheng C, Zhang J, Lu D, Zhuang J, Xing S, Feng J, Yang D, Yan X. 2012. Recognition of CD146 as an ERM-binding protein offers novel mechanisms for melanoma cell migration. Oncogene 31:306-321.
28. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38: 228-233.
29. Zhang Y, Zheng C, Zhang J, Yang D, Feng J, Lu D, Yan X. 2008. Generation and characterization of a panel of monoclonal antibodies against distinct epitopes of human CD146. Hybridoma (Larchmt.) 27: 345-352.
30. Redmond EM, Cullen JP, Cahill PA, Sitzmann JV, Stefansson S, Lawrence DA, Okada SS. 2001. Endothelial cells inhibit flow-induced smooth muscle cell migration: role of plasminogen activator inhibitor-1. Circulation 103:597-603.
31. Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R, Zamborsky ED, Herman S, Sarkar PK, Ericksen MB, Dhanabal M, Simons M, Post M, Kufe DW, Weichselbaum RR, Sukhatme VP, Kalluri R. 2000. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res. 60:2520-2526.
32. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, Dimmeler S. 2009. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324:1710-1713.
33. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA. 1994. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35:101-111.
34. Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, Guerin KI, Sapieha P, Stahl A, Willett KL, Smith LE. 2009. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat. Protoc. 4:1565-1573.
35. Bowie A, Moynagh PN, O'Neill LA. 1996. Mechanism of NF kappa B activation by interleukin-1 and tumour necrosis factor in endothelial cells. Biochem. Soc. Trans. 24:2S. http://www.biochemsoctrans.org.
36. Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, Krah NM, Seaward MR, Willett KL, Aderman CM, Guerin KI, Hua J, Lofqvist C, Hellstrom A, Smith LEH. 2010. The mouse retina as an angiogenesis model. Invest. Ophthalmol. Vis. Sci. 51:2813-2826.
37. Gardiner TA, Gibson DS, de Gooyer TE, de la Cruz VF, McDonald DM, Stitt AW. 2005. Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am. J. Pathol. 166:637-644.
38. Ouhtit A, Gaur RL, Abd Elmageed ZY, Fernando A, Thouta R, Trappey AK, Abdraboh ME, El-Sayyad HI, Rao P, Raj MG. 2009. Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146. Biochim. Biophys. Acta 1795:130-136.
39. Liu JW, Nagpal JK, Jeronimo C, Lee JE, Henrique R, Kim MS, Ostrow KL, Yamashita K, van Criekinge V, Wu G, Moon CS, Trink B, Sidransky D. 2008. Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancer. Prostate 68:418-426.
40. Jean D, Bar-Eli M. 2000. Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family. Mol. Cell. Biochem. 212:19-28.
41. Chen Y, Gorski DH. 2008. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111:1217-1226.
42. Urbich C, Kaluza D, Fromel T, Knau A, Bennewitz K, Boon RA, Bonauer A, Doebele C, Boeckel JN, Hergenreider E, Zeiher AM, Kroll J, Fleming I, Dimmeler S. 2012. MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood 119: 1607-1616.
43. Solovey AN, Gui L, Chang L, Enenstein J, Browne PV, Hebbel RP. 2001. Identification and functional assessment of endothelial P1H12. J. Lab. Clin. Med. 138:322-331.
44. Karali M, Peluso I, Gennarino VA, Bilio M, Verde R, Lago G, Dolle P, Banfi S. 2010. miRNeye: a microRNA expression atlas of the mouse eye. BMC Genomics 11:715. doi:10.1186/1471-2164-11-715.
45. Hackler L, Jr, Wan J, Swaroop A, Qian J, Zack DJ. 2010. MicroRNA profile of the developing mouse retina. Invest. Ophthalmol. Vis. Sci. 51: 1823-1831.
46. Bai Y, Bai X, Wang Z, Zhang X, Ruan C, Miao J. 2011. MicroRNA-126 inhibits ischemia-induced retinal neovascularization via regulating angiogenic growth factors. Exp. Mol. Pathol. 91:471-477.
47. Shen J, Yang X, Xie B, Chen Y, Swaim M, Hackett SF, Campochiaro PA. 2008. MicroRNAs regulate ocular neovascularization. Mol. Ther. 16: 1208-1216.
48. Castanotto D, Rossi JJ. 2009. The promises and pitfalls of RNAinterference-based therapeutics. Nature 457:426-433.
49. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS. 2003. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21:635-637.
50. Zhou Q, Gallagher R, Ufret-Vincenty R, Li X, Olson EN, Wang S. 2011. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters. Proc. Natl. Acad. Sci. U. S. A. 108:8287-8292.